0001235802-11-000185.txt : 20111115
0001235802-11-000185.hdr.sgml : 20111115
20111115111550
ACCESSION NUMBER: 0001235802-11-000185
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111114
FILED AS OF DATE: 20111115
DATE AS OF CHANGE: 20111115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROSENOW EDWARD C III
CENTRAL INDEX KEY: 0001241294
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31812
FILM NUMBER: 111206078
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001023024
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 582301143
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 BARCLAY BLVD
CITY: LINCOLNSHIRE
STATE: IL
ZIP: 60069
BUSINESS PHONE: 8474780500
MAIL ADDRESS:
STREET 1: 111 BARCLAY BLVD
CITY: LINCOLNSHIRE
STATE: IL
ZIP: 60069
FORMER COMPANY:
FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC
DATE OF NAME CHANGE: 19991027
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0304
4
2011-11-14
0
0001023024
BIOSANTE PHARMACEUTICALS INC
BPAX
0001241294
ROSENOW EDWARD C III
C/O BIOSANTE PHARMACEUTICALS, INC.
111 BARCLAY BOULEVARD
LINCOLNSHIRE
IL
60069
1
0
0
0
Common Stock
2011-11-14
4
P
0
3000
2.37
A
20540
D
/s/ Phillip B. Donenberg, attorney-in-fact
2011-11-15